| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/HEP.21199 |
| P698 | PubMed publication ID | 16628666 |
| P2093 | author name string | Tatyana Masyuk | |
| Nicholas LaRusso | |||
| P2860 | cites work | The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein | Q24292750 |
| Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease | Q24531988 | ||
| Identification of a locus for autosomal dominant polycystic liver disease, on chromosome 19p13.2-13.1 | Q24538950 | ||
| Polycystic disease of the liver | Q28283470 | ||
| Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells | Q28505110 | ||
| Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases | Q28576110 | ||
| Activation of the MEK5/ERK5 cascade is responsible for biliary dysgenesis in a rat model of Caroli's disease | Q28578050 | ||
| The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia | Q29615732 | ||
| The genetics and physiology of polycystic kidney disease | Q34179146 | ||
| An incredible decade for the primary cilium: a look at a once-forgotten organelle | Q34465976 | ||
| Polycystic kidney disease: new understanding in the pathogenesis | Q34548724 | ||
| Biliary dysgenesis in the PCK rat, an orthologous model of autosomal recessive polycystic kidney disease | Q35103361 | ||
| Molecular genetics of autosomal recessive polycystic kidney disease | Q35637400 | ||
| PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats | Q35764727 | ||
| Liver disease in autosomal recessive polycystic kidney disease | Q36263614 | ||
| Matrix metalloproteinase activity in human intrahepatic biliary epithelial cell lines from patients with autosomal dominant polycystic kidney disease | Q41248259 | ||
| Epidermal growth factor receptor tyrosine kinase inhibition is not protective in PCK rats | Q45116487 | ||
| Molecular characterization of hepatocystin, the protein that is defective in autosomal dominant polycystic liver disease. | Q47368927 | ||
| Defects in cholangiocyte fibrocystin expression and ciliary structure in the PCK rat. | Q52552433 | ||
| IL-6 induces hepatic inflammation and collagen synthesis in vivo. | Q54638501 | ||
| Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway | Q61623437 | ||
| Autosomal recessive polycystic kidney disease: long-term sonographic findings in patients surviving the neonatal period | Q72156999 | ||
| Polycystic kidney disease--the ciliary connection | Q73087592 | ||
| Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor | Q73322106 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | polycystic liver disease | Q246002 |
| P304 | page(s) | 906-908 | |
| P577 | publication date | 2006-05-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Polycystic liver disease: new insights into disease pathogenesis | |
| P478 | volume | 43 |
| Q33987179 | Activation of Trpv4 reduces the hyperproliferative phenotype of cystic cholangiocytes from an animal model of ARPKD. |
| Q37719446 | Case study: polycystic livers in a transgenic mouse line |
| Q37317821 | Cholangiociliopathies: genetics, molecular mechanisms and potential therapies |
| Q36277264 | Cholangiocyte cilia express TRPV4 and detect changes in luminal tonicity inducing bicarbonate secretion. |
| Q36953076 | Cholangiocyte primary cilia in liver health and disease |
| Q28572123 | HDAC6 is overexpressed in cystic cholangiocytes and its inhibition reduces cystogenesis |
| Q33703710 | Hepato-renal pathology in pkd2ws25/- mice, an animal model of autosomal dominant polycystic kidney disease |
| Q47125278 | Increased YAP Activation Is Associated With Hepatic Cyst Epithelial Cell Proliferation in ARPKD/CHF. |
| Q35185224 | Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases |
| Q30403670 | Liver masses: a clinical, radiologic, and pathologic perspective. |
| Q36075880 | Meningeal tumor: A rare extrahepatic association in patients with polycystic liver disease enrolled for liver transplantation |
| Q36945198 | MicroRNA15a modulates expression of the cell-cycle regulator Cdc25A and affects hepatic cystogenesis in a rat model of polycystic kidney disease |
| Q37431350 | MicroRNAs in cholangiociliopathies |
| Q28742454 | PPAR-gamma agonist ameliorates kidney and liver disease in an orthologous rat model of human autosomal recessive polycystic kidney disease |
| Q42174609 | Pathobiology of biliary epithelia and cholangiocarcinoma: proceedings of the Henry M. and Lillian Stratton Basic Research Single-Topic Conference |
| Q33949172 | Polycystic liver diseases. |
| Q35678557 | Proliferation-Independent Initiation of Biliary Cysts in Polycystic Liver Diseases |
| Q36667245 | Sirolimus reduces polycystic liver volume in ADPKD patients |
| Q40867711 | TGR5 in the Cholangiociliopathies |
Search more.